"FU-IFM2009" Database Post IFM/DFCI 2009 Study

• Conditions: Multiple Myeloma

• Registration Number: NCT03679351
• Lead Sponsor: University Hospital, Toulouse

Brief Summary

Extension of patient follow-up of the IFM/DFCI 2009 study over a period of 4 years (that is, from 01 December 2016 to 30 November 2020) during which patients will be followed up in the normal course of care and according to the usual care of the centers, with collection of the needed data about twice a year by the investigators

Detailed Description

Not available

Study Timeline

• Study Start: 2018-07-15
• Study First Submitted: 2018-09-19
• Study First Submitted QC: 2018-09-19
• Study First Posted: 2018-09-20
• Status Verified: 2020-07
• Last Update Submitted: 2020-07-29
• Last Update Posted: 2020-07-30
• Primary Completion: 2020-11-30
• Study Completion: 2020-11-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 675

Inclusion Criteria

• Patient randomized in the IFM/DFCI 2009 study.
• Patient still alive must give their non-opposition to the post IFM/DFCI 2009 study data collection until 30 November 2020
• Patient non-opposition.

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
progression free survival	4 years	number of deaths

Secondary Outcome Measures

Name	Time	Method
overall long-term survival	4 years	number of deaths
secondary primary malignancies	4 years	number of secondary primary malignancies

Trial Locations

Locations (1)

CHU de Toulouse; 🇫🇷 Toulouse, France